Malawi vs Sierra Leone: Access to anti-retroviral drugs, female
Malawi
93.0%
in 2024
Sierra Leone
95.0%
in 2024
Malawi rank
22nd
Sierra Leone rank
19th
Access to anti-retroviral drugs, female over time
- Malawi
- Sierra Leone
How they compare
Sierra Leone currently reports 95.0% against 93.0% in Malawi, a difference of 2.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Sierra Leone ahead.
Malawi ranks 22nd and Sierra Leone ranks 19th of 141 countries.
Malawi has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Malawi | Sierra Leone | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 7.1% | 1.5% | 5.6% | Malawi |
| 2010s | 62.4% | 28.4% | 34.0% | Malawi |
| 2020s | 91.6% | 80.4% | 11.2% | Malawi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Malawi or Sierra Leone?
- Sierra Leone, at 95.0% against 93.0% in Malawi as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Malawi and Sierra Leone?
- 2.0%, with Sierra Leone ahead.
- How many years of comparable data are there for Malawi and Sierra Leone?
- 25 years are reported by both, from 2000 to 2024.
- How do Malawi and Sierra Leone rank globally for access to anti-retroviral drugs, female?
- Malawi ranks 22nd and Sierra Leone ranks 19th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.